EPB41L3 and lung cancer: Loss of the 4.1B/DAL-1 protein leads to a substantial decrease in the expression of numerous EMT markers, including E-cadherin and β-catenin in lung cancer cell lines [27], which agrees with our EPB41L3 knockdown data.